Overview
Xiaoyu Zhu practices practicing medicine in Shanghai, China.
Zhu is highly rated in 1 condition, according to our data. Their clinical expertise encompasses HER-2 Positive Breast Cancer, Breast Cancer, Agranulocytosis, and Lung Cancer.
They are actively involved in clinical research, co-authoring 20 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xiaoyu Zhu
Is Xiaoyu Zhu a top-rated expert for HER-2 Positive Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Xiaoyu Zhu is classified as an Advanced expert for HER-2 Positive Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xiaoyu Zhu participate in research or clinical trials?
Yes. Xiaoyu Zhu has published 20 articles and abstracts on conditions like HER-2 Positive Breast Cancer. You can view a list of Xiaoyu Zhu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- HER-2 Positive Breast Cancer
- Experienced
- AgranulocytosisZhu isExperienced. Learn about Agranulocytosis.
- Breast CancerZhu isExperienced. Learn about Breast Cancer.
- Lung CancerZhu isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)